Devices · Labs · Equipment
Strategy for
Medtech.
Our medtech practice serves emerging innovation and large medtech across devices, medical equipment, and diagnostics. Common strategy questions range from market assessments to business models and pricing approaches.
FEATURED PERSPECTIVE
- Biopharma ,
- Payers ,
- Medtech ,
The road ahead for genomic testing
Read the analysis →
"PRS test developers need to ensure their tests improve outcomes and can change care patterns."
— Recon analysis
Keys to harnessing the value of digital biomarkers in clinical trials
- By Lilian Zhang and Nikhil Bhojwani
- Biopharma ,
- Medtech ,
- Digital ,
For years, digital biomarkers have seemed like a promising way to tran…
Read more
The road ahead for genomic testing
- By Sarah Dolman
- Biopharma ,
- Payers ,
- Medtech ,
New molecular diagnostics, especially tests based on next-generation s…
Read more
AI in healthcare III: COVID-19 applications and implications
- By Sophie Ranen and Nikhil Bhojwani
- Biopharma ,
- Payers ,
- Providers ,
- Medtech ,
- Digital ,
COVID-19 has accelerated the adoption of AI in healthcare. AI based to…
Read more
SELECTED CASE STUDIES
How we've helped Medtech
Representative engagements, anonymized. Each pairs deep sector knowledge with rigorous, structured analysis.
No results found.
No results found.
- Providers, Digital health, Early Stage
Strategy for digital behavioral health
Telehealth vendor threatened by AI
Telehealth, Digital, Mental Health